Sort by
Refine Your Search
-
conformational analyses to establish molecular solution conformations to drive lead compound optimizations. Contribute to the development of new technology in ATCM such as microscale high-throughput NMR, high
-
established departmental priorities. Interact with external vendors to obtain quotes and submit purchases where applicable. Qualifications Must-Have Bachelor of Science degree in Engineering, Computer
-
chemistry team in a lab-based role in Bothell Washington to support novel ADC technology development. The successful candidate will participate in research projects involving the design and synthesis of novel
-
, chemists, and protein engineers to innovate and develop first-in-class oncology therapies. The successful candidate should have a record of being a strong scientist, team player, strategic thinker, and an
-
experienced biomedical engineer with automation experience to support several mRNA vaccine programs. In this position, you will actively support the technology transfer and integration of a new laboratory with
-
, many backgrounds, and many strengths, but we share one goal: to improve the lives of patients. An Automation Scientist in Analytical Technology and Compound Management (ATCM) within the Liquid Store
-
Plan, execute and analyze in vivo pharmacology studies Characterize new in vivo mouse models, including syngeneic tumor and genetically engineered mouse (GEM) models, to study biologic mechanisms and
-
organize/prioritize work efficiently and effectively Experience designing and building building reusable code infrastructure and work with engineering teams Strong written and verbal communication skills
-
Pharmaceutical Sciences Small Molecule group at Pfizer is working diligently to bring new cutting-edge medicines to patients around the world. Our team members use the latest science and technology to characterize
-
combines research and technology units that have deep disease area expertise and cutting-edge science and platforms to discover and develop innovative therapeutic programs in small molecules and